Immunome, Inc. (IMNM)
18.71
+0.80
(+4.50%)
USD |
NASDAQ |
Nov 06, 16:00
19.49
+0.78
(+4.17%)
After-Hours: 20:00
Immunome Free Cash Flow : -219.09M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -219.09M |
| March 31, 2026 | -205.52M |
| December 31, 2025 | -200.60M |
| September 30, 2025 | -191.84M |
| June 30, 2025 | -185.92M |
| March 31, 2025 | -161.35M |
| December 31, 2024 | -117.97M |
| September 30, 2024 | -92.59M |
| June 30, 2024 | -65.53M |
| March 31, 2024 | -45.80M |
| Date | Value |
|---|---|
| December 31, 2023 | -8.399M |
| September 30, 2023 | 2.654M |
| June 30, 2023 | 3.733M |
| March 31, 2023 | 1.511M |
| December 31, 2022 | -28.94M |
| September 30, 2022 | -29.00M |
| June 30, 2022 | -25.60M |
| March 31, 2022 | -21.12M |
| December 31, 2021 | -18.30M |
| September 30, 2021 | -17.59M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Revolution Medicines, Inc. | -1.441B |
| Erasca, Inc. | -98.08M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -61.69M |
| Cash from Investing (Quarterly) | -304.35M |
| Cash from Financing (Quarterly) | 1.058M |
| Free Cash Flow Per Share (Quarterly) | -0.5638 |
| Free Cash Flow to Equity (Quarterly) | -64.91M |
| Free Cash Flow to Firm (Quarterly) | -63.87M |
| Free Cash Flow Yield | -11.50% |